Tromboz, Gemostaz I Reologiya impact factor, indexing, ranking (2023)


Tromboz,

Aim and Scope

Tromboz, Gemostaz I Reologiya is a research journal that publishes research related to Medicine; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Hemostasis and Rheology LLC. The ISSN of this journal is 20781008, 26871483. Based on the Scopus data, the SCImago Journal Rank (SJR) of Tromboz, Gemostaz i Reologiya is 0.112.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Tromboz, Gemostaz i Reologiya

According to Clarivate's JCR, the journals indexed in SCIE/SSCI have an impact factor.

Tromboz, Gemostaz I Reologiya Ranking

Journal Rank: 25096
SJR (SCImago Journal Rank): 0.112
Quartile: Q4
H-Index: 2

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.



Important Metrics

Journal Title: Tromboz, Gemostaz i Reologiya
Publisher: Hemostasis and Rheology LLC
ISSN: 20781008, 26871483
Type: journal
Journal Scope: Medicine; Pharmacology, Toxicology and Pharmaceutics
Country: Russian Federation
H-Index: 2
SJR: 0.112
Quartile: Biochemistry (medical) (Q4); Hematology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Physiology (medical) (Q4)

Tromboz, Gemostaz i Reologiya Indexing

The Tromboz, Gemostaz i Reologiya is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Tromboz, Gemostaz I Reologiya Quartile

The latest Quartile of Tromboz, Gemostaz i Reologiya is Q4.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Tromboz, Gemostaz I Reologiya?

If your research is related to Medicine; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of Tromboz, Gemostaz i Reologiya and send your manuscript.

Tips for publishing in Tromboz, Gemostaz I Reologiya:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Publication Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • It is published by Hemostasis and Rheology LLC.
  • The journal is indexed in UGC CARE, Scopus.
  • The (SJR) SCImago Journal Rank is 0.112.

Sources: Tromboz, Gemostaz i Reologiya







Similiar Journals


REGULATORY TOXICOLOGY AND PHARMACOLOGY
ISSN: 0273-2300
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

ALCOHOL
ISSN: 0741-8329
Publisher: ELSEVIER SCIENCE INC

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN: 0362-1642
Publisher: ANNUAL REVIEWS

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
ISSN: 1742-7835
Publisher: WILEY

BMC PHARMACOLOGY & TOXICOLOGY
ISSN:
Publisher: BMC

CHEMICO-BIOLOGICAL INTERACTIONS
ISSN: 0009-2797
Publisher: ELSEVIER IRELAND LTD

DRUG AND CHEMICAL TOXICOLOGY
ISSN: 0148-0545
Publisher: TAYLOR & FRANCIS LTD

DRUGS
ISSN: 0012-6667
Publisher: ADIS INT LTD

DRUG SAFETY
ISSN: 0114-5916
Publisher: ADIS INT LTD

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
ISSN: 1382-6689
Publisher: ELSEVIER

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.